Please login to the form below

Not currently logged in
Email:
Password:

Research Pipeline

This page shows the latest Research Pipeline news and features for those working in and with pharma, biotech and healthcare.

Sanofi sheds jobs in R&D restructuring

Sanofi sheds jobs in R&D restructuring

make a meaningful difference for patients and to maximise the productivity of our research engine.”. ... It has 84 projects in its pipeline, with oncology accounting for 26 projects.

Latest news

  • Merck KGaA exec takes top job at UK biotech Kymab Merck KGaA exec takes top job at UK biotech Kymab

    With its competitive antibody research platforms and evolving clinical pipeline, Kymab is well positioned as it progresses into an integrated discovery and development company.”. ... The company’s most advanced pipeline candidate is KY1005, a

  • AZ signs $20m deal with Seres for microbiome project AZ signs $20m deal with Seres for microbiome project

    AstraZeneca is funding a research project at Seres Therapeutics to explore how the bacteria in the gut can affect – and possible enhance – the effect of cancer immunotherapies. ... Just last month, the company announced it would cut a third of its

  • CRUK forges £30m ‘post-Brexit’ R&D alliance CRUK forges £30m ‘post-Brexit’ R&D alliance

    No single organisation or country is going to beat cancer on its own,” commented Dr Iain Foulkes, executive director of research and innovation at CRUK. ... Our Accelerator Award funding will lay the groundwork for a Europe and UK research pipeline,

  • GSK: we won’t be splitting up any time soon GSK: we won’t be splitting up any time soon

    The company has 27 immunomodulatory new molecular entities (NME) in clinical trials, around 60% of its total clinical pipeline. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance

  • Daily Brief: GSK unveils R&D plan, Keytruda OK'd for lymphoma by NICE Daily Brief: GSK unveils R&D plan, Keytruda OK'd for lymphoma by NICE

    News from pharma, biotech and healthcare. 23andMe alliance part of GSK’s new research plan. ... GSK’s CEO Emma Walmsley (pictured) has restated her determination to revive the firm’s research pipeline in a statement this morning, ahead of an

More from news
Approximately 3 fully matching, plus 44 partially matching documents found.

Latest Intelligence

  • Heart failure therapy embarks on a new era Heart failure therapy embarks on a new era

    There are also a number of other drugs coming through the research pipelines. ... Pipeline growing. While Entresto and ivabradine promise to make a significant impact in HF, there are also a number of other investigational drugs coming through the

  • Eisai: Bucking the trend with R&D growth Eisai: Bucking the trend with R&D growth

    Research pipeline. Research at Eisai is focused on three key areas: neuroscience, oncology and vascular/immunological diseases. . ... Commercial expansion. But it's not just in research spending that Eisai is bucking industry trends.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics